IS7940A - Samsetningar sem samanstanda af fósturblóðrauða og bakteríuinneitri og mögulega viðbótar hlutum fósturlifrar - Google Patents

Samsetningar sem samanstanda af fósturblóðrauða og bakteríuinneitri og mögulega viðbótar hlutum fósturlifrar

Info

Publication number: IS7940A
Authority: IS; Iceland
Prior art keywords: fetal hemoglobin; bacterial; additional components; intoxicants; fetus
Prior art date: 2003-02-18

Application number

IS7940A

Other languages

English (en)

Other versions

IS2294B (is

Inventor

Westphal Otto

Wälli Thierry

Gorczynski Reginald

Müller Silke

Mach Jean-Pierre

Hartmann Alfred

Bessler Wolfgang

Hofmann Petra

Zähringer Ulrich

Alexander Christian

Vor Dem Esche Ulrich

J. Ulmer Artur

Verdini Antonio

Original Assignee

Clinique La Prairie Research S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-18

Filing date

2005-07-18

Publication date

2005-07-18

2005-07-18 Application filed by Clinique La Prairie Research S.A. filed Critical Clinique La Prairie Research S.A.

2005-07-18 Publication of IS7940A publication Critical patent/IS7940A/is

2007-10-15 Publication of IS2294B publication Critical patent/IS2294B/is

Links

108010044495 Fetal Hemoglobin Proteins 0.000 title abstract 3
230000001580 bacterial effect Effects 0.000 title 1
210000003754 fetus Anatomy 0.000 title 1
239000002158 endotoxin Substances 0.000 abstract 2
206010027654 Allergic conditions Diseases 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000001605 fetal effect Effects 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
208000026278 immune system disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
210000004185 liver Anatomy 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Gastroenterology & Hepatology (AREA)
Nutrition Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Virology (AREA)
Zoology (AREA)
Microbiology (AREA)
Oncology (AREA)
Physiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Molecular Biology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS7940A 2003-02-18 2005-07-18 Samsetningar sem samanstanda af fósturblóðrauða og bakteríuinneitri og mögulega viðbótarhlutum fósturlifrar, þar sem fósturblóðrauðinn og mögulegir viðbótarhlutar fósturlifrar eru ekki fengnir úr mennskum vef IS2294B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03003687A EP1449535B1 (en)	2003-02-18	2003-02-18	Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
PCT/EP2004/001553 WO2004073728A2 (en)	2003-02-18	2004-02-18	Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components

Publications (2)

Publication Number	Publication Date
IS7940A true IS7940A (is)	2005-07-18
IS2294B IS2294B (is)	2007-10-15

Family

ID=32731533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7940A IS2294B (is)	2003-02-18	2005-07-18	Samsetningar sem samanstanda af fósturblóðrauða og bakteríuinneitri og mögulega viðbótarhlutum fósturlifrar, þar sem fósturblóðrauðinn og mögulegir viðbótarhlutar fósturlifrar eru ekki fengnir úr mennskum vef

Country Status (20)

Country	Link
US (1)	US7968103B2 (is)
EP (2)	EP1449535B1 (is)
JP (1)	JP4619352B2 (is)
KR (1)	KR101102481B1 (is)
CN (1)	CN1750840A (is)
AT (1)	ATE324903T1 (is)
AU (1)	AU2004212703C1 (is)
BR (1)	BRPI0407311B8 (is)
CA (1)	CA2514485C (is)
DE (1)	DE60304989T2 (is)
DK (1)	DK1449535T3 (is)
ES (1)	ES2263859T3 (is)
IL (1)	IL169760A (is)
IS (1)	IS2294B (is)
MX (1)	MXPA05008797A (is)
NO (1)	NO334003B1 (is)
NZ (1)	NZ541417A (is)
PL (1)	PL211789B1 (is)
RU (1)	RU2366449C2 (is)
WO (1)	WO2004073728A2 (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007103427A2 (en) *	2006-03-06	2007-09-13	Wang Xiang H	Medical use of bilirubin and its structural analogues
US20090181078A1 (en) *	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
WO2010006200A2 (en) *	2008-07-09	2010-01-14	Board Of Regents, The University Of Texas System	Triggered release of drugs from polymer particles
WO2010123798A2 (en)	2009-04-20	2010-10-28	Galenbio, Inc.	Compositions for transfection of biomolecules into cells
EP2789343A1 (en) *	2013-04-11	2014-10-15	Clinique La Prairie	Novel hemoglobin-derived peptide based pharmaceutical compositions
EP3019186A4 (en) *	2013-07-12	2017-03-29	Patrick J. Casey	Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4473647A (en) *	1981-02-27	1984-09-25	Amf Inc.	Tissue culture medium
US4987237A (en) *	1983-08-26	1991-01-22	Ribi Immunochem Research, Inc.	Derivatives of monophosphoryl lipid A
EP0271521A4 (en)	1986-05-09	1989-11-14	Sloan Kettering Inst Cancer	Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment.
ATE126698T1 (de)	1989-06-30	1995-09-15	American Cyanamid Co	Verwendung eines phagozytise-aktievierenden stoffes : lps oder il-2 zur herstellung eines arzneimittels zur behandlung von staphylococcus- aureus-infektionen bei kühen.
EP0472467A3 (en)	1990-08-20	1993-03-17	Chiba Flour Milling Co. Ltd.	Lps-containing analgesics and veterinary analgesics
JPH0499481A (ja) *	1990-08-20	1992-03-31	Chiba Seifun Kk	新規細菌、新規ｌｐｓ、新規免疫機能活性化剤、新規動物用免疫機能活性化剤
JPH0690745A (ja) *	1990-08-20	1994-04-05	Chiba Seifun Kk	Ｌｐｓ産生菌、ｌｐｓ、ｌｐｓを含む医薬及び動物薬
JPH04187640A (ja) *	1990-11-22	1992-07-06	Chiba Seifun Kk	経口・経皮免疫機能促進剤、動物用経口・経皮免疫機能促進剤
DE539610T1 (de) *	1991-10-26	1993-12-16	Torf Ets	Verfahren und Zusammensetzung zur Bestimmung der Immunologischen Aktivität von aktiven Substanzen enthaltende Lösungen.
JP3199081B2 (ja) *	1992-11-13	2001-08-13	味の素株式会社	抗腫瘍剤
DE4338812A1 (de) *	1993-11-15	1995-05-18	Braun Melsungen Ag	Verwendung von Lösungen von vernetztem Hämoglobin zur Bekämpfung des septischen und hämorrhagischen Schocks bei Säugetieren
US5648343A (en) *	1994-02-28	1997-07-15	The University Of Georgia Research Foundation	Method for treating LPS-mediated disorders
US5580724A (en) *	1994-03-25	1996-12-03	Board Of Regents, The University Of Texas System	Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis
US20020065211A1 (en) *	1995-03-23	2002-05-30	Biopure Corporation	Increasing function of organs having reduced red blood cell flow
DK0863866T3 (da)	1995-10-06	2001-06-11	Vertex Pharma	Butyrat-prodrugs afledt af mælkesyre
WO1997025061A1 (en) *	1996-01-09	1997-07-17	Bristol-Myers Squibb Company	De-myristolated lipopolysaccharide of gram-negative bacteria
EP0856592A1 (en)	1997-02-04	1998-08-05	N.V. Bekaert S.A.	A coating comprising layers of diamond like carbon and diamond like nanocomposite compositions
JP4256938B2 (ja) *	1997-02-04	2009-04-22	ナムローゼ・フェンノートシャップ・ベーカート・ソシエテ・アノニム	ダイヤモンド状カーボン及びダイヤモンド状ナノコンポジット組成物の層を有するコーティング物
RU2140283C1 (ru) *	1998-12-15	1999-10-27	Товарищество с ограниченной ответственностью "Биотех"	Фармацевтический препарат на основе интерлейкина-2 (варианты)
EP2292657A1 (en) *	1999-11-12	2011-03-09	Baxter Biotech Technology S.A.R.L.	Reduced side-effect hemoglobin compositions
EP2295968B1 (en) *	1999-12-03	2012-09-19	Baxter International Inc.	Pyrogenicity test for use with automated immunoassay systems
US20010026800A1 (en) *	2000-01-07	2001-10-04	Michael Jacob G.	Selective activation of a TH1 or TH2 lymphocyte regulated immune response
WO2002017965A1 (en) *	2000-08-28	2002-03-07	Akira Awaya	Medicinal compositions
DE10103211C1 (de) *	2001-01-24	2002-07-18	Ursula Kastner	Kulturmedium

2003
- 2003-02-18 DK DK03003687T patent/DK1449535T3/da active
- 2003-02-18 EP EP03003687A patent/EP1449535B1/en not_active Expired - Lifetime
- 2003-02-18 DE DE60304989T patent/DE60304989T2/de not_active Expired - Lifetime
- 2003-02-18 ES ES03003687T patent/ES2263859T3/es not_active Expired - Lifetime
- 2003-02-18 AT AT03003687T patent/ATE324903T1/de active
2004
- 2004-02-18 WO PCT/EP2004/001553 patent/WO2004073728A2/en not_active Ceased
- 2004-02-18 JP JP2006501878A patent/JP4619352B2/ja not_active Expired - Lifetime
- 2004-02-18 CN CNA2004800044076A patent/CN1750840A/zh active Pending
- 2004-02-18 BR BRPI0407311A patent/BRPI0407311B8/pt not_active IP Right Cessation
- 2004-02-18 US US10/545,500 patent/US7968103B2/en active Active
- 2004-02-18 KR KR1020057015264A patent/KR101102481B1/ko not_active Expired - Lifetime
- 2004-02-18 NZ NZ541417A patent/NZ541417A/en not_active IP Right Cessation
- 2004-02-18 EP EP04712020A patent/EP1601371A2/en not_active Withdrawn
- 2004-02-18 CA CA2514485A patent/CA2514485C/en not_active Expired - Lifetime
- 2004-02-18 AU AU2004212703A patent/AU2004212703C1/en not_active Expired
- 2004-02-18 MX MXPA05008797A patent/MXPA05008797A/es active IP Right Grant
- 2004-02-18 PL PL378573A patent/PL211789B1/pl unknown
- 2004-02-18 RU RU2005126141/15A patent/RU2366449C2/ru active
2005
- 2005-07-18 IS IS7940A patent/IS2294B/is unknown
- 2005-07-19 IL IL169760A patent/IL169760A/en active IP Right Grant
- 2005-09-02 NO NO20054087A patent/NO334003B1/no unknown

Also Published As

Publication number	Publication date
IS2294B (is)	2007-10-15
NZ541417A (en)	2008-08-29
BRPI0407311B8 (pt)	2021-11-30
KR20050111596A (ko)	2005-11-25
IL169760A (en)	2012-09-24
BRPI0407311A (pt)	2006-02-21
RU2005126141A (ru)	2006-01-27
KR101102481B1 (ko)	2012-01-05
WO2004073728A3 (en)	2004-10-07
WO2004073728A2 (en)	2004-09-02
EP1449535B1 (en)	2006-05-03
AU2004212703C1 (en)	2009-05-21
EP1449535A1 (en)	2004-08-25
PL378573A1 (pl)	2006-05-02
US20080075742A1 (en)	2008-03-27
US7968103B2 (en)	2011-06-28
NO20054087L (no)	2005-11-08
NO20054087D0 (no)	2005-09-02
DE60304989D1 (de)	2006-06-08
AU2004212703B2 (en)	2008-10-30
BRPI0407311B1 (pt)	2020-12-29
AU2004212703A1 (en)	2004-09-02
NO334003B1 (no)	2013-11-11
DE60304989T2 (de)	2007-03-29
EP1601371A2 (en)	2005-12-07
RU2366449C2 (ru)	2009-09-10
CN1750840A (zh)	2006-03-22
CA2514485C (en)	2013-11-05
PL211789B1 (pl)	2012-06-29
JP2006518350A (ja)	2006-08-10
DK1449535T3 (da)	2006-09-11
JP4619352B2 (ja)	2011-01-26
ES2263859T3 (es)	2006-12-16
CA2514485A1 (en)	2004-09-02
MXPA05008797A (es)	2006-05-25
ATE324903T1 (de)	2006-06-15

Publication	Publication Date	Title
SG163517A1 (en)	2010-08-30	Antiviral compounds and methods
ZA200507070B (en)	2008-12-31	Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
MX2010001733A (es)	2010-07-06	Compustos de imidazo[1,2-a]pirazina para tratamiento de infecciones virales tales como hepatitis.
EP1594444A3 (en)	2005-11-03	Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
TNSN06071A1 (en)	2007-10-03	Use of modified cyclosporins for the treatment of hcv disorders
EP1492563A4 (en)	2006-03-15	COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF INFECTIONS WITH THE HERPES SIMPLEX VIRUS
MY144318A (en)	2011-08-29	Methods of treating hiv infection.
EP2182006A3 (en)	2010-09-15	Compositions and methods for the treatment of immune related diseases
WO2006066079A3 (en)	2006-12-14	Pyridazinone compounds
NO941786D0 (no)	1994-05-11	Uretaner og ureaer som induserer cytokinproduksjon
ZA200803493B (en)	2009-12-30	Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
IL178395A0 (en)	2007-02-11	Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
EA200600280A1 (ru)	2006-10-27	Композиции на основе производных липопептидных антибиотиков и способы их применения
WO2009029384A3 (en)	2009-05-28	Compounds for the treatment of hepatitis c
AU2002303817A1 (en)	2002-12-03	Compositions and methods for treating or preventing convulsions or seizures
WO2010052575A3 (en)	2010-08-26	Ngna compositions and methods of use
AU2003270498A1 (en)	2005-03-07	Topical veterinary compositions and methods for the treatment and prevention of infection
WO2006034001A3 (en)	2006-11-23	Methods of treating hiv infection
IS7940A (is)	2005-07-18	Samsetningar sem samanstanda af fósturblóðrauða og bakteríuinneitri og mögulega viðbótar hlutum fósturlifrar
ATE420852T1 (de)	2009-01-15	Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
ZA200608358B (en)	2008-09-25	Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
GB0123276D0 (en)	2001-11-21	Uses of agents that bind immune-system components
WO2005080549A3 (de)	2005-12-08	Trioxacarcine und deren verwendung gegen infektionskrankheiten
WO2007056527A3 (en)	2009-05-14	Diagnostic and therapeutic methods and agents
AU2003299493A1 (en)	2004-05-13	Compositions and methods for the treatment of hepatitis c virus infection